Search Results

The interleukin-6, serotonin transporter, and monoamine oxidase A genes and endurance performance during the South African Ironman Triathlon

Authors: de Milander, Liesl; Stein, Dan J.; Collins, Malcolm

Source: Applied Physiology, Nutrition, and Metabolism, Volume 34, Number 5, 1 October 2009 , pp. 858-865(8)

Publisher: NRC Research Press

Current strategies in the treatment of Parkinson's disease and a personalized approach to management

Authors: Diaz, Nancy L; Waters, Cheryl H

Source: Expert Review of Neurotherapeutics, Volume 9, Number 12, December 2009 , pp. 1781-1789(9)

Publisher: Expert Reviews

Atypical Depression: A Comprehensive Review

Authors: Pae, Chi-Un; Tharwani, Haresh; Marks, David M.; Masand, Prakash S.; Patkar, Ashwin A.

Source: CNS Drugs, Volume 23, Number 12, 1 December 2009 , pp. 1023-1037(15)

Publisher: Adis International

Established therapies and novel targets in the treatment of Parkinson's disease

Authors: Dézsi, Livia; Vécsei, László

Source: Expert Review of Clinical Pharmacology, Volume 2, Number 6, November 2009 , pp. 631-644(14)

Publisher: Expert Reviews

Serotonin released from amacrine neurons is scavenged and degraded in bipolar neurons in the retina

Authors: Ghai, Kanika; Zelinka, Christopher; Fischer, Andy J.

Source: Journal of Neurochemistry, Volume 111, Number 1, October 2009 , pp. 1-14(14)

Publisher: Blackwell Publishing

Functional mechanism of neuroprotection by inhibitors of type B monoamine oxidase in Parkinson's disease

Authors: Naoi, Makoto; Maruyama, Wakako

Source: Expert Review of Neurotherapeutics, Volume 9, Number 8, August 2009 , pp. 1233-1250(18)

Publisher: Expert Reviews

Neuropeptide and Sigma Receptors as Novel Therapeutic Targets for the Pharmacotherapy of Depression

Authors: Paschos, Konstantinos A.; Veletza, Stavroula; Chatzaki, Ekaterini

Source: CNS Drugs, Volume 23, Number 9, 1 September 2009 , pp. 755-772(18)

Publisher: Adis International

The Use of Iontophoresis in the Administration of Nicotine and New Non-Nicotine Drugs through the Skin for Smoking Cessation

Authors: Escobar-Chavez, Jose J.; Merino, Virginia; Lopez-Cervantes, Miriam; Rodriguez-Cruz, Isabel M.a.r.l.e.n.; Quintanar-Guerrero, David; Ganem-Quintanar, Adriana

Source: Current Drug Discovery Technologies, Volume 6, Number 3, September 2009 , pp. 171-185(15)

Publisher: Bentham Science Publishers

Levodopa-related wearing-off in Parkinson's disease: identification and management

Authors: Pahwa, Rajesh; Lyons, Kelly E.

Source: Current Medical Research and Opinion, Volume 25, Number 4, April 2009 , pp. 841-849(9)

Publisher: Informa Healthcare

Selegiline transdermal system: a novel treatment option for major depressive disorder

Authors: Nandagopal, Jayasree J; DelBello, Melissa P

Source: Expert Opinion on Pharmacotherapy, Volume 10, Number 10, July 2009 , pp. 1665-1673(9)

Publisher: Informa Healthcare

Antidepressants and Falls in the Elderly

Authors: Darowski, Adam; Chambers, Sally-Ann C.F.; Chambers, David J.

Source: Drugs & Aging, Volume 26, Number 5, May 5 2009 , pp. 381-394(14)

Publisher: Adis International

Current investigational drugs for major depression

Authors: Kulkarni, Shrinivas K; Dhir, Ashish

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 767-788(22)

Publisher: Informa Healthcare

Duloxetine: A Review of its Use in the Treatment of Generalized Anxiety Disorder

Authors: Carter, Natalie J.; McCormack, Paul L.

Source: CNS Drugs, Volume 23, Number 6, 30 May 2009 , pp. 523-541(19)

Publisher: Adis International

Editorial [Hot Topic: New Antidepressant Drugs: Beyond Monoaminergic Mechanisms (Executive Editors: Cecilio Alamo and Francisco Lopez-Munoz)]

Authors: Alamo, Cecilio; Lopez-Munoz, Francisco

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1559-1562(4)

Publisher: Bentham Science Publishers

New Approaches to Antidepressant Drug Design: Cytokine-Regulated Pathways

Authors: Nishida, Akira; Miyaoka, Tsuyoshi; Inagaki, Takuji; Horiguchi, Jun

Source: Current Pharmaceutical Design, Volume 15, Number 14, May 2009 , pp. 1683-1687(5)

Publisher: Bentham Science Publishers

5-hydroxytryptamine induced relaxation in the pig urinary bladder neck

Authors: Recio, Paz; Barahona, María Victoria; Orensanz, Luis M; Bustamante, Salvador; Martínez, Ana Cristina; Benedito, Sara; García-Sacristán, Albino; Prieto, Dolores; Hernández, Medardo

Source: British Journal of Pharmacology, Volume 157, Number 2, May 2009 , pp. 271-280(10)

Publisher: Blackwell Publishing

Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A

Authors: Alves, Ema; Summavielle, Teresa; Alves, Cecília Juliana; Custódio, José Barata Antunes; Fernandes, Eduarda; de Lourdes Bastos, Maria; Tavares, Maria Amélia; Carvalho, Félix

Source: Addiction Biology, Volume 14, Number 2, April 2009 , pp. 185-193(9)

Publisher: Blackwell Publishing

In a recent report, Decision Resources suggests that second-line patient share of monoamine oxidase B (MAO B) inhibitors has increased

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 574, 2009-03-21 , pp. 7-7(1)

Publisher: Adis International

Relevant Issues in the Monitoring and the Toxicology of Antidepressants

Authors: Wille, Sarah; Cooreman, Sarah; Neels, Hugo; Lambert, Willy

Source: Critical Reviews in Clinical Laboratory Sciences, Volume 45, Number 1, January 2008 , pp. 25-89(65)

Publisher: Informa Healthcare

Drugs Used to Treat Parkinson's Disease, Present Status and Future Directions

Author: Abdel-Salam, Omar M.E.

Source: CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets, Volume 7, Number 4, October 2008 , pp. 321-342(22)

Publisher: Bentham Science Publishers